Dyne Therapeutics shareholders elect Hurwitz, Kersten; approve say-on-pay

Dyne Therapeutics, Inc.

Edward Hurwitz elected with 62.9M votes for, 27.4M withheld; Dirk Kersten with 58.3M for, 32.0M withheld.
Non-binding advisory say-on-pay approved: 74.4M for, 15.8M against, 81.6K abstain.
Stockholders recommend advisory vote on executive compensation every year (90.2M votes); company will hold annual say-on-pay.
Ratification of Deloitte & Touche LLP as independent auditor for FY2025: 105.6M for, 19.8K against.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.